AHR · American Healthcare REIT, Inc. · Documents

$57.78 -0.86 (-1.47%) At close · Nov 13 Play latest call Q3 2026 earnings call transcript

S&P 400 member Russell 1000 member Rebalance outlook locked

Market Cap

$13.41B

232.07M

Volume · Nov 13 2.58M Avg daily vol (3M) 3.1M

The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →

2023

Apr 11

Current report 8-K Events of Apr 6

Director or officer change, or executive pay, Regulation FD disclosure

Apr 11

Proxy statement DEFA14A

Proxy statement

Mar 20

Current report 8-K

Regulation FD disclosure

Mar 17

Current report 8-K Events of Mar 15

Regulation FD disclosure, Other events

Mar 17

Annual report 10-K FY2022, ended Dec 31

Annual report for FY2022

Revenue $1.41B ▲ 25.6% Net loss $81.3M Diluted EPS -$1.24

Mar 7

Current report 8-K Events of Mar 1

Entered into a material agreement, New debt or off-balance-sheet obligation

Feb 17

Current report 8-K

Charter or bylaw amendment, or fiscal year change

Jan 10

Current report 8-K Events of Jan 6

Director or officer change, or executive pay, Regulation FD disclosure

2022

Dec 21

Current report 8-K

Regulation FD disclosure

Dec 13

Current report 8-K Events of Dec 12

Other events

Nov 16

Current report 8-K Events of Nov 14

Change to shareholders' rights, Charter or bylaw amendment, or fiscal year change, Regulation FD disclosure, Other events

Nov 14

Quarterly report 10-Q FY2022 Q3, ended Sep 30

Quarterly report for FY2022 Q3

Revenue $368.31M ▲ 28.4% Net loss $13.51M Diluted EPS -$0.05

Sep 29

Current report 8-K Events of Sep 28

Other events

Sep 20

Current report 8-K Events of Sep 16

Other events

Sep 16

Current report 8-K

Regulation FD disclosure

Aug 31

Current report 8-K Events of Aug 30

Director or officer change, or executive pay, Regulation FD disclosure

Aug 19

Current report 8-K

Regulation FD disclosure

Aug 15

Quarterly report 10-Q FY2022 Q2, ended Jun 30

Quarterly report for FY2022 Q2

Revenue $326.23M ▲ 18.0% Net loss $17.31M Diluted EPS -$0.07

Aug 4

Current report 8-K

Regulation FD disclosure

Jul 18

Current report 8-K Events of Jul 14

Director or officer change, or executive pay, Regulation FD disclosure

Jun 16

Current report 8-K Events of Jun 15

Shareholder vote results

Jun 15

Current report 8-K

Regulation FD disclosure

Jun 14

Current report 8-K

Regulation FD disclosure

May 26

Current report 8-K

Regulation FD disclosure

May 16

Quarterly report 10-Q FY2022 Q1, ended Mar 31

Quarterly report for FY2022 Q1

Revenue $318.97M ▲ 26.1% Net loss $2.96M Diluted EPS -$0.01

Apr 8

Proxy statement DEF 14A

Proxy statement

Apr 8

Proxy statement DEFA14A

Proxy statement

Mar 29

Current report 8-K Events of Mar 28

Regulation FD disclosure, Other events

Mar 25

Current report 8-K Events of Mar 24

Regulation FD disclosure, Other events

Mar 25

Annual report 10-K FY2021, ended Dec 31

Annual report for FY2021

Revenue $1.12B ▲ 5.1% Net loss $47.79M Diluted EPS -$0.24

Mar 14

Current report 8-K

Regulation FD disclosure

Jan 25

Current report 8-K Events of Jan 19

Entered into a material agreement, Ended a material agreement, New debt or off-balance-sheet obligation, Other events

2021

Dec 9

Current report 8-K

Other events

Dec 1

Current report 8-K

Regulation FD disclosure

Nov 19

Current report 8-K

Regulation FD disclosure, Other events

Nov 15

Quarterly report 10-Q FY2021 Q3, ended Sep 30

Quarterly report for FY2021 Q3

Revenue $37.21M Net loss $5.78M

Nov 2

Current report 8-K/A Events of Sep 30

Current report

Oct 8

Current report 8-K/A Events of Sep 30

Current report

Oct 5

Current report 8-K Events of Oct 1

Entered into a material agreement, Director or officer change, or executive pay, Charter or bylaw amendment, or fiscal year change, Regulation FD disclosure, Other events

Oct 1

Current report 8-K Events of Sep 30

Completed an acquisition or sale of assets, Director or officer change, or executive pay, Charter or bylaw amendment, or fiscal year change, Shareholder vote results, Regulation FD disclosure, Other events

Sep 30

Current report 8-K

Regulation FD disclosure

Sep 1

Current report 8-K

Regulation FD disclosure, Other events

Aug 13

Quarterly report 10-Q FY2021 Q2, ended Jun 30

Quarterly report for FY2021 Q2

Revenue $37.18M ▼ 3.9% Net loss $3.77M

Aug 2

Current report 8-K Events of Aug 1

Other events

Jul 27

Registration statement S-4/A

Registration statement

Jul 23

Current report 8-K

Regulation FD disclosure, Other events

Jul 16

Registration statement S-4

Registration statement

Jul 1

Current report 8-K

Other events

Jun 24

Current report 8-K Events of Jun 23

Entered into a material agreement, Regulation FD disclosure, Other events

May 28

Current report 8-K

Regulation FD disclosure, Other events

Showing 101–150 of 185 documents

Key facts CIK 1632970 CUSIP 398182303 13F (30d) 477 filings 438 filers Visit website Investor relations